Masimo (NASDAQ:MASI – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Telehealth and Telecare News since 2005 ...

Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable ...

Couch co-op and split-screen tend to be associated with consoles as the terms conjure images of friends playing Mario Party and Crash Team Racing on a TV, but PC owners have plenty of options as well.

The US Food and Drug Administration (FDA) has published draft guidance aimed at improving the performance of pulse oximeters across all skin colours, following research suggesting the medical devices ...

Joe Kiani, the CEO of Masimo, the company that filed the patent infringement suit against Apple that led to the ITC's Exclusion Order, recently said that consumers should avoid using the pulse ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

IRVINE, Calif., January 08, 2025--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday ...